BSX Long Call Strategy
BSX (Boston Scientific Corporation), in the Healthcare sector, (Medical - Devices industry), listed on NYSE.
Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe. Its business is strategically organized into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Within these divisions, the company provides a comprehensive portfolio of solutions addressing various gastrointestinal and pulmonary ailments, as well as urological and pelvic health concerns. This extends to advanced implantable devices for managing cardiac rhythm disorders, such as cardioverter-defibrillators, cardiac resynchronization therapy devices, and pacemakers, complemented by remote patient management systems. Furthermore, Boston Scientific offers sophisticated technologies for diagnosing and treating complex heart rate and rhythm irregularities. These encompass 3-D cardiac mapping and navigation tools, along with a suite of specialized catheters (including ablation, diagnostic, mapping, and intracardiac ultrasound types), delivery sheaths, and related accessories.
BSX (Boston Scientific Corporation) trades in the Healthcare sector, specifically Medical - Devices, with a market capitalization of approximately $76.43B, a trailing P/E of 20.72, a beta of 0.57 versus the broader market, a 52-week range of 42.2-109.5, average daily share volume of 20.1M, a public-listing history dating back to 1992, approximately 59K full-time employees. These structural characteristics shape how BSX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.57 indicates BSX has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a long call on BSX?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
BSX snapshot
As of August 14, 2026, spot at $51.93, ATM IV 35.90%, IV rank 45.81%, expected move 10.29%. The long call on BSX below is built from the August 14, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 28-day expiry.
Why this long call structure on BSX specifically: BSX IV at 35.90% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 10.29% (roughly $5.34 on the underlying). The 28-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated BSX expiries trade a higher absolute premium for lower per-day decay. Position sizing on BSX should anchor to the underlying notional of $51.93 per share and to the trader's directional view on BSX stock.
BSX long call setup
The BSX long call below is built from the August 14, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With BSX at $51.93 on that close, the first option leg uses a $52.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed BSX chain at a 28-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 BSX shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $52.00 | $2.08 |
BSX long call risk and reward
- Net Premium / Debit
- -$207.50
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$207.50
- Breakeven(s)
- $54.08
- Risk / Reward Ratio
- Unbounded
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
BSX long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on BSX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$207.50 |
| $11.49 | -77.9% | -$207.50 |
| $22.97 | -55.8% | -$207.50 |
| $34.45 | -33.7% | -$207.50 |
| $45.93 | -11.5% | -$207.50 |
| $57.41 | +10.6% | +$333.95 |
| $68.90 | +32.7% | +$1,482.04 |
| $80.38 | +54.8% | +$2,630.13 |
| $91.86 | +76.9% | +$3,778.22 |
| $103.34 | +99.0% | +$4,926.31 |
When traders use long call on BSX
Long calls on BSX express a bullish thesis with defined risk; traders use them ahead of BSX catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
BSX thesis for this long call
The market-implied 1-standard-deviation range for BSX extends from approximately $46.59 on the downside to $57.27 on the upside. A BSX long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current BSX IV rank near 45.81% is mid-range against its 1-year distribution, so the IV signal is neutral; the long call thesis on BSX should anchor more to the directional view and the expected-move geometry. As a Healthcare name, BSX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to BSX-specific events.
BSX long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. BSX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move BSX alongside the broader basket even when BSX-specific fundamentals are unchanged. Long-premium structures like a long call on BSX are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current BSX chain quotes before placing a trade.
Frequently asked questions
- What is a long call on BSX?
- A long call on BSX is the long call strategy applied to BSX (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With BSX stock at $51.93 on the August 14, 2026 close, the strikes shown on this page are snapped to the nearest listed BSX chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are BSX long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the BSX long call priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 35.90%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$207.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a BSX long call?
- The breakeven for the BSX long call priced on this page is roughly $54.08 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The BSX market-implied 1-standard-deviation expected move in the same options snapshot is approximately 10.29%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on BSX?
- Long calls on BSX express a bullish thesis with defined risk; traders use them ahead of BSX catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current BSX implied volatility affect this long call?
- BSX ATM IV is at 35.90% with IV rank near 45.81%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.